LinkedInXFacebook
Subscribe
Orthopedics This Week
  • My Feed
  • |Posts
  • |Events
  • |MSK Innovations
  • |Power Rankings
  • |Masterclasses
  • |Technology Awards
  • Press Releases
  • |Advertising
  • |Job Board
  • Spine
  • ◆Joints
  • ◆Upper Extremities
  • ◆Foot & Ankle
  • ◆Sports Medicine
  • ◆Pain Mgmt
  • ◆Trauma
  • ◆Biologics
  • ◆Technology
  • ◆People
  • ◆Company News
  • ◆Legal & Regulatory
Home/Large Joints and Extremities/Vitamin D No Cure for Knee OA
Large Joints and Extremities

Vitamin D No Cure for Knee OA

January 28, 2013 2 min read Premium comments

Advertisement

Vitamin D No Cure for Knee OA
Source: Wikimedia Commons and Bradley J
Secondary

Another hopeful theory bites the dust! Vitamin D supplements had no impact on the pain of knee osteoarthritis (OA), researchers discovered in a randomized placebo-controlled trial of 146 people with symptomatic knee OA. Vitamin D, the absence of which causes rickets, is essential for bone health. But its connection to OA is, we now know, probably non-existent.

The patients were enrolled at Tufts Medical Center in Boston between March 2006 and June 2009 and randomly assigned to receive oral cholecalciferol or a placebo. The initial dose was 2, 000 IU a day with dose escalation, if necessary, to achieve a serum level of more than 36 ng/ml.

According to Michael Smith, writing in MedPage Today, the primary outcomes of the study were to be knee pain severity, as measured on the Western Ontario and McMaster Universities’ pain scale, and loss of cartilage as measured by MRI.

The results: baseline knee function was significantly worse in the treatment group than in the placebo group. Knee pain decreased in both groups, dropping by an average of 2.31 points in the treatment group and 1.46 in the placebo group, but the differences were not statistically significant. The percentage of cartilage volume fell by 4.3% and 4.25% in the treatment and placebo groups but, again, the difference was not statistically significant. The lead researchers, Timothy McAlindon, D.M. of Tufts, and his colleagues, reported their results in an article in the January 9 issue of the Journal of the American Medical Association.

The authors wrote that the idea that vitamin D might help victims of osteoarthritis was based on its role in bone health, combined with the importance of bone changes in OA and epidemiologic observations that hinted at slower disease progression among patients with higher vitamin D levels. They added that, no medical treatments are presently available that alter the course of the disease.

Smith quoted Joseph Guettler, M.D., of Beaumont Health System in Royal Oak, Michigan, as saying that one of the main limitations of the study was the focus on vitamin D, which is essential for bone health but less so for maintenance of healthy cartilage. “When it comes to articular cartilage, we might have been barking up the wrong tree here, ” Guettler told MedPage Today. “I think future study needs to focus on components of healthy articular cartilage, such as glucosamine-chondroitin [and] hyaluronic acid derivatives that are known to lubricate and nourish healthy joints.”

React:

Discussion

14
DS
Dr. Sarah MitchellOrthopedic Surgeon · Mayo Clinic

This is a fascinating development. In my practice we've seen similar outcomes with the revised protocol. The key differentiator seems to be patient selection criteria. Has anyone else noticed the correlation with BMI thresholds?

8
JT
James Thornton, MDSpine Fellow · HSS

Great point. I'd push back slightly on the conclusion, the sample size in the cited study is too small to draw population-level inferences. That said, the directional signal is compelling and worth a larger RCT.

5
RP
R. PatelSports Medicine · Stanford

We implemented a similar approach last year. Early results are promising but we're still gathering 12-month follow-up data. Happy to share our protocol if anyone is interested.

Join the conversation

Orthopedic professionals are discussing this. Sign in and upgrade to read every comment and add your voice.

Subscribe

Get Full Access

Read every OTW article and join member discussions for $24.99/month.

Get Full Access

Advertisement

Advertisement

Advertisement

Orthopedics This Week

The most trusted source in orthopedic industry news since 2005. Covering spine, joints, trauma, biologics, and the business of orthopedics.

A publication of RRY Publications, LLC

LinkedInXFacebook

Categories

  • Spine
  • Joints
  • Upper Extremities
  • Foot & Ankle
  • Sports Medicine
  • Pain Mgmt
  • Trauma
  • Biologics
  • Technology
  • People
  • Company News
  • Legal & Regulatory

Resources

  • Subscribe
  • Community Posts
  • Job Board
  • Press Release Opportunities
  • Power Rankings
  • About OTW
  • Advertise
  • Contact Us

Get Full Access

Unlimited articles, community posts, and Power Rankings.

Get Full Access

Plans start at $24.99/mo · Annual saves 20%

© 2026 Orthopedics This Week · RRY Publications, LLC

Privacy PolicyTerms of ServiceCookie Policy